alzheimer-s-disease

Documents about alzheimer-s-disease

• Circadian rhythms and chronotherapy in Alzheimer's disease: Mechanisms and therapeutic implications#642311Europe PMC
• 2026 Alzheimer's disease facts and figures.#135628NCBI PubMed Central
• Norepinephrine and dopamine Imbalance in the medial frontal gyrus from patients with Alzheimer's disease#5380Europe PMC
• The role of ionotropic glutamate receptors in Alzheimer's disease: A scientometric analysis#5614Europe PMC
• Insight Into the Epigenetics of Alzheimer's Disease: A computational study from Human Interactome#31381Zenodo (CERN)
• Associations of plasma biomarkers with age in the presenilin-1 E280A autosomal dominant Alzheimer's disease kindred#259841Europe PMC
• The Cellular Mechanisms of Alzheimer's Disease Protection by the PILRA G78R Variant#321492BYU ScholarsArchive
• Does Following the MIND Diet Slow Cognitive Decline and Alzheimer’s Disease?#424421DigitalCommons@USU
• Cognition in Non-Demented Elderly With a Family History of Alzheimer's Disease#433098DigitalCommons@USU
• Translational Feasibility of Curcumin for Treatment of Alzheimer’s Disease: A Critical Appraisal of Clinical Challenges#231310Europe PMC
• Influence of Speech Disfluencies and Prompt Optimization in LLM-Based Alzheimer's Disease Classification#246121DigitalCommons@Kennesaw State University
• Glial Cells in Behavioral and Psychological Symptoms of Alzheimer's Disease#246391Europe PMC
• Translational Feasibility of Curcumin for Treatment of Alzheimer's Disease: A Critical Appraisal of Clinical Challenges#246393Europe PMC
• Disease modifying treatments for Alzheimer's disease: Clinician perspectives.#159714NCBI PubMed Central
• Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer’s disease with hydromethylthionine mesylate using external control data✰✰✰#123242Europe PMC
• Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control data#125809Europe PMC
• Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features#614704eScholarship
• Impairments of attention in Alzheimer’s disease#648501Spiral
• Olfactory decline tracks central-to-peripheral spread of tau pathology in Alzheimer's disease#120130Europe PMC
• Public Policy Implications of Liability Regimes for Injuries Caused by Persons with Alzheimer's Disease#167575Digital Commons @ University of Georgia School of Law
• AN INVESTIGATION INTO THE NEUROPROTECTIVE POTENTIAL OF ERGOTHIONEINE IN THE AMYLOID HYPOTHESIS OF ALZHEIMER’S DISEASE#254779ScholarBank@NUS
• Quantitative susceptibility mapping of the brain is associated with inflammatory changes in Alzheimer's disease related areas#333047Europe PMC
• A paradigm of the diagnosis and treatment for the whole process of Alzheimer's disease.#214365PubMed
• Engineering nanobodies for drug delivery systems in Alzheimer's disease.#9730PubMed
• Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associated with increased risk of clinical progression in early Alzheimer's disease#182053Europe PMC
• Serum amino acid levels are associated with brain hypometabolism in patients across the Alzheimer's disease continuum#5363Europe PMC
• Heterogeneous patterns of cognitive decline in Alzheimer's disease across three domains of cognition#144950HAL (France)
• Screening for Alzheimer's disease in the community using an AI-driven screening platform: design of the PREDICTOM study#182054Europe PMC
• Naphthyl-functionalized acetamide derivatives: Promising agents for cholinesterase inhibition and antioxidant therapy in Alzheimer's disease#197436Repositorio UNAB
• A computational framework to predict the spreading of Alzheimer’s disease#248588Spiral
• Dexmedetomidine Exerts Multi-Level Effects to Ameliorate Alzheimer’s Disease Pathology in the Adult Zebrafish Brain#256625İzmir Yüksek Teknoloji Enstitüsü
• An automated plasma‐based proteotyping immunoassay for APOE ε4 zygosity classification in Alzheimer's disease#274386HAL (France)
• Centralized Review of Alzheimer’s Disease and Related Dementias Biomedical Repositories and Computational Methods#314719Europe PMC
• Blood serum from individuals with Alzheimer’s disease alters microglial phagocytosis in vitro#353989HAL (France)
• Alzheimer's disease in patients prescribed statins: A real-world data analysis of U.S. patient health records#5615Europe PMC
• Myelin injury and degraded myelin vesicles in Alzheimer’s disease#612114eScholarship
• Amyloid‐related imaging abnormalities (ARIA) in anti‐amyloid therapies for Alzheimer's disease: An update from the Alzheimer's Association ARIA workgroup#125786Europe PMC
• Diagnostic Performance of Plasma Biomarkers of Alzheimer's Disease Compared With CSF Markers#391041ClinicalTrials.gov
• Alzheimer’s Disease Brain Phenotypes are Age-dependent#5466Europe PMC
• Metrifonate for Alzheimer's disease.#461496NCBI PubMed Central
• Integrating the physical environment into Alzheimer's disease and Alzheimer's disease related dementias research: A Gateway Exposome Coordinating Center (GECC) agenda on gaps and priorities.#125276NCBI PubMed Central
• New Alzheimer’s Disease Diagnostics and Psychological Clinical Perspectives#397098OSF
• The HTT gene influences plasma neurofilament light chain and brain metabolism in prodromal Alzheimer's disease#436342IRIS
• Synthesis, molecular docking, molecular dynamics and DFT studies of new thiazole derivatives as dual cholinesterase inhibitors against alzheimer’s disease#450228Recep Tayyip Erdoğan University Institutional Repository
• Astrocytes, via RTP801, contribute to cognitive decline by disrupting GABAergic-regulated connectivity and driving neuroinflammation in an Alzheimer's disease mouse model#184965Dipòsit Digital de la Universitat de Barcelona
• Alzheimer's disease knowledge graph enhances knowledge discovery and disease prediction.#247544NCBI PubMed Central
• Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers#612146eScholarship
• The impact of learning about financial compensation on enrollment in Alzheimer's disease longitudinal research.#162235PubMed
• Candesartan's Effects on Alzheimer's Disease And Related Biomarkers#435804ClinicalTrials.gov
• Structural heterogeneity reveals distinct amyloidopathies in Alzheimer's disease#651089bioRxiv / medRxiv